Plasma brain natriuretic peptide in obstructive sleep apnea
References (20)
- et al.
Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea
Am J Hypertens
(2003) - et al.
Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction
Chest
(2002) - et al.
The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure
J Sleep Res
(1998) - et al.
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study
JAMA
(2000) - et al.
The occurrence of sleep-disordered breathing among middle-aged adults
N Engl J Med
(1993) - et al.
Sympathetic neural mechanisms in obstructive sleep apnea
J Clin Invest
(1995) - et al.
Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients
Am J Respir Crit Care Med
(2002) - et al.
Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome
Respiration
(1992) - et al.
Reduced stroke volume related to pleural pressure in obstructive sleep apnea
J Appl Physiol
(1983) - et al.
High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs
Congest Heart Fail
(2003)
Cited by (56)
A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure
2023, American Journal of CardiologyBiomarkers of cardiovascular stress in obstructive sleep apnea
2016, Clinica Chimica ActaInteractions Between Sleep Disordered Breathing and Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
2010, American Journal of CardiologyCitation Excerpt :Our finding that the E/e′ ratio, a measurement of left ventricular filling pressures,25 is also increased in patients with SDB is consistent with previous studies and suggests that SDB may contribute to diastolic dysfunction,26 resulting in left atrial enlargement and increased risk for AF. Although increased filling pressures and impaired diastolic function may occur because of a thickened and noncompliant ventricular chamber27,28 due to HC, increased E/e′ ratio and elevated overnight atrial natriuretic peptide levels, reflecting increased left atrial pressure, have also been demonstrated in patients with SDB29,30 without HC. As listed in Table 1, the SDB group had a higher rate of treated hypertension, and this is consistent with the recognition of SDB as a cause of systemic hypertension.31
Characteristics of sleep-disordered breathing in Japanese patients with type 2 diabetes mellitus
2010, Metabolism: Clinical and Experimental
This study was supported by Grants HL-65176, HL-61560, HL-70602, and M01-RR00585 from the National Institutes of Health, Bethesda, Maryland.